2019 Duchenne Platform Trial Stakeholder Meeting
This stakeholder meeting was hosted by Parent Project Muscular Dystrophy, I-ACT for Children, and the Critical Path Institute.
Parent Project Muscular Dystrophy (“PPMD”) hosts conferences, meetings, and webinars which bring together clinicians, researchers, industry leaders, government representatives, and others to present their work and innovative concepts to benefit the Duchenne community, particularly our patients and their families. The conferences, meetings, and webinars are intended to be an opportunity to exchange information for educational purposes. Each PPMD conference, meeting, or webinar may include opinions, statements, materials, presentations, data, images, videos, documentation and other information (collectively, “Materials”) expressed or otherwise shared by presenters whom PPMD has invited to participate. The Materials are for informational purposes only. The statements, views and opinions expressed at any presentation or in any Materials are those solely of the presenter and not of PPMD. Further, PPMD does not endorse or recommend any presenter or any views mentioned at any conference/meeting/webinar or in the Materials. Under no circumstances will PPMD (or its directors, officers, employees, or agents) be liable for the accuracy, quality or reliability of any of the presentations or Materials; any defamatory, offensive, or illegal conduct of presenters; or any direct, indirect, incidental, special or consequential damages arising from any presentations or Materials.